ReviewCancers2020

Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Albert Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.